Trade-Ideas LLC identified

VCA

(

WOOF

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified VCA as such a stock due to the following factors:

  • WOOF has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $39.5 million.
  • WOOF has traded 23,079 shares today.
  • WOOF is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in WOOF with the Ticky from Trade-Ideas. See the FREE profile for WOOF NOW at Trade-Ideas

More details on WOOF:

VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments, Animal Hospital and Laboratory. WOOF has a PE ratio of 26. Currently there are 5 analysts that rate VCA a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for VCA has been 637,300 shares per day over the past 30 days. VCA has a market cap of $5.5 billion and is part of the services sector and diversified services industry. The stock has a beta of 0.96 and a short float of 1.7% with 2.25 days to cover. Shares are up 24.6% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates VCA as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.

Highlights from the ratings report include:

  • WOOF's revenue growth has slightly outpaced the industry average of 11.8%. Since the same quarter one year prior, revenues rose by 12.8%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • VCA INC has improved earnings per share by 23.9% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, VCA INC increased its bottom line by earning $2.56 versus $1.53 in the prior year. This year, the market expects an improvement in earnings ($2.90 versus $2.56).
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Health Care Providers & Services industry and the overall market, VCA INC's return on equity exceeds that of both the industry average and the S&P 500.
  • Investors have apparently begun to recognize positive factors similar to those we have mentioned in this report, including earnings growth. This has helped drive up the company's shares by a sharp 25.05% over the past year, a rise that has exceeded that of the S&P 500 Index. We feel that the stock's sharp appreciation over the last year has driven it to a price level which is now somewhat expensive compared to the rest of its industry. The other strengths this company shows, however, justify the higher price levels.
  • The net income growth from the same quarter one year ago has exceeded that of the S&P 500, but is less than that of the Health Care Providers & Services industry average. The net income increased by 20.7% when compared to the same quarter one year prior, going from $38.30 million to $46.23 million.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.